Article
Variable cardiovascular phenotypes associated with SMAD2 pathogenic variants.
Human mutation - 1 Dec 2018
Granadillo Jorge L, Chung Wendy K, Hecht Leah, Corsten-Janssen Nicole, Wegner Daniel, Nij Bijvank Sebastiaan W A, Toler Tomi L, Pineda-Alvarez Daniel E, Douglas Ganka, Murphy Joshua J, Shimony Joshua, Shinawi Marwan
Abstract excerpt
SMAD2 is a downstream effector in the TGF-β signaling pathway, which is important for pattern formation and tissue differentiation. Pathogenic variants in SMAD2 have been reported in association with arterial aneurysms and dissections and in large cohorts of subjects with complex congenital heart disease (CHD). We used whole exome sequencing (WES) to investigate the molecular cause of CHD and other congenital...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
